Analytical Data
-
Gene name
FCRL6
- Application
-
Alternative Names
FCRL6；FCRH6；Fc receptor-like Protein 6
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6DN72
-
Expression Region
20-307aa
-
AA Sequence
LYLQAWPNPVFEGDALTLRCQGWKNTPLSQVKFYRDGKFLHFSKENQTLS MGAATVQSRGQYSCSGQVMYIPQTFTQTSETAMVQVQELFPPPVLSAIPS PEPREGSLVTLRCQTKLHPLRSALRLLFSFHKDGHTLQDRGPHPELCIPG AKEGDSGLYWCEVAPEGGQVQKQSPQLEVRVQAPVSRPVLTLHHGPADPA VGDMVQLLCEAQRGSPPILYSFYLDEKIVGNHSAPCGGTTSLLFPVKSEQ DAGNYSCEAENSVSRERSEPKKLSLKGSQVLFTPASNW
-
Molecular Weight
47 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FCRL6, or Fc receptor-like 6, is a member of the Fc receptor-like family, which plays a significant role in the immune system by regulating various immune responses. This receptor is predominantly expressed on B cells and certain immune cells, indicating its crucial function in immune regulation and signaling. Recent studies have highlighted FCRL6's involvement in autoimmune diseases, infections, and tumor immunity, suggesting it may serve as a potential biomarker or therapeutic target. Recombinant FCRL6 protein research has gained interest due to its ability to interact with immunoglobulins and influence B cell differentiation, activation, and survival. Understanding the structure and function of FCRL6 through recombinant protein studies could provide insights into its role in modulating immune responses and its potential implications for treating immune-related disorders. Consequently, the generation of FCRL6 recombinant proteins is vital for investigating its biochemical properties and therapeutic potential, facilitating the development of novel strategies to manipulate immune responses in various clinical contexts.
